SEVERE NEONATAL HYPOGLYCEMIA DUE TO CONGENITAL HYPERINSULINISM: DIAGNOSTIC AND THERAPEUTIC CHALLENGES
Excellence in Pediatrics Abstracts · 2025 · 17
DOI: 10.66584/eip2025-164 ↗Kurz gefasst
Fachartikel in der Zeitschrift Excellence in Pediatrics Abstracts, 2025. Verfasst von Maylin Abigail Matienzo Rafael und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Congenital hyperinsulinism (CHI) is the most common cause of persistent hypoglycemia in neonates and infants, with an estimated incidence of 1:30,000-50,000 live births. It results from inappropriate insulin secretion, leading to suppressed ketogenesis and lipolysis, and poses a significant risk for irreversible neurological damage. Early diagnosis and treatment are essential; however, limited access to genetic and imagin studies in resource-constrained settings hampers appropriate management. Case Description: We report a term male neonate (38 weeks, birth weight 4,345g) born to a mother with polyhydramnios and urinary tract infection. Shortly after birth, he presented with symptomatic hypoglycemia (plasma glucose 1mg/dL), lethargy, tremors, and decreased reflexes. Despite high glucose infusion rates and diazoxide therapy up to 20 mg/kg/day, hypoglycemia persisted. Echocardiography revealed multiple cardiac anomalies (PFO, ASD, VSD,PDA), and cranial ultrasound showed bilateral thalamic vasculopathy. Persistent seizures and respiratory failure required mechanical ventilation. Due to limited resources, 18F-DOPA PET imaging and genetic testing were not performed. The patient developed multi-organ complications and passed away following cardiorespiratory arrest on day 46. (Table 1)
Discussion
Refractory CHI is frequently associated with KATP-channel mutations, often requiring surgical intervention. Lack of access to genetic testing and advanced imaging delays appropriate treatment decisions, including ocreotide use or pancreatectomy. This case illustrates the high morbidity and mortality of untreated or refractory CHI, emphasizing the need for early diagnosis and multidisciplinary care.
Conclusion
CHI requires prompt recognition, metabolic and genetic evaluation, and specialized management to prevent severe neurological and systemic complications.
Zitieren
APA
Rafael, M. A. M., Miñano, J. C. V., Guaña, O. P. Q., Gomez, M. D. B., Merino, P. A. R., & Valladares, E. S. C. (2025). SEVERE NEONATAL HYPOGLYCEMIA DUE TO CONGENITAL HYPERINSULINISM: DIAGNOSTIC AND THERAPEUTIC CHALLENGES. Excellence in Pediatrics Abstracts, 17. https://doi.org/10.66584/eip2025-164
Vancouver
Rafael MAM, Miñano JCV, Guaña OPQ, Gomez MDB, Merino PAR, Valladares ESC. SEVERE NEONATAL HYPOGLYCEMIA DUE TO CONGENITAL HYPERINSULINISM: DIAGNOSTIC AND THERAPEUTIC CHALLENGES. Excellence in Pediatrics Abstracts. 2025;17. doi:10.66584/eip2025-164
BibTeX
@article{Rafael2025,
author = {Rafael, Maylin Abigail Matienzo and Miñano, Julio Cesar Vicuña and Guaña, Orlando Paul Quishpe and Gomez, Michelle Denisse Brito and Merino, Paolo Augusto Romero and Valladares, Erick Sebastián Chiguano},
title = {SEVERE NEONATAL HYPOGLYCEMIA DUE TO CONGENITAL HYPERINSULINISM: DIAGNOSTIC AND THERAPEUTIC CHALLENGES},
journal = {Excellence in Pediatrics Abstracts},
year = {2025},
volume = {17},
doi = {10.66584/eip2025-164}
}
EUVIMED